iopamidol NDC 70436-125

NDC codes

FDA NDC Directory

Product NDC (as listed)70436-125Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70436-0125Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
70436-125-82	70436012582	10 VIAL, SINGLE-DOSE in 1 CARTON (70436-125-82) / 50 mL in 1 VIAL, SINGLE-DOSE (70436-125-37)Marketed from Apr 15, 2024

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): iopamidol
Generic name (nonproprietary): iopamidol
Active ingredients: Iopamidol — 510 mg/mL
Dosage form: Injection, Solution
Route: Intravascular
Labeler: Slate Run Pharmaceuticals, LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 217134
Marketing start: Apr 15, 2024
Listing expires: Dec 31, 2026
Other FDA classes: X-Ray Contrast Activity (Mechanism)
Identifiers: Product ID 70436-125_3a1c5a58-814e-8d80-e063-6394a90ac71dSPL ID 3a1c5a58-814e-8d80-e063-6394a90ac71dSPL set ID 69e9ab05-88f8-45f9-8bc1-ed33ab1385f0UNII JR13W81H44
Pharmacologic class: Radiographic Contrast Agent

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

NDC on a medical claim

N470436012582 followed by a unit qualifier and the quantity

Package 70436-0125-82. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 17, 2025. This label includes a boxed warning.

Indications (excerpt from the label)

Iopamidol Injection, USP is a radiographic contrast agent indicated for: Intra-arterial Procedures * ( 1.1 ) Cerebral arteriography in adults Peripheral arteriography in adults Selective visceral arteriography and aortography in adults Coronary arteriography and cardiac ventriculography in adults Angiocardiography in pediatric patients Intravenous Procedures * ( 1.2 ) Excretory urography in adults and pediatric patients Computed tomography (CT) of head and body in adults and pediatric patients Peripheral venography in adults * Specific concentrations are recommended for each type of imaging procedure. ( 2.2 , 2.3 , 2.4 ) 1.1 Intra-arterial Procedures* Cerebral arteriography in adults Periphe…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 217134

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 217134
Product	Strength	Form · route	Labeler	Product NDC
iopamidol	Iopamidol 408 mg/mL	Injection, SolutionIntravascular	Slate Run Pharmaceuticals, LLC	70436-211
iopamidol	Iopamidol 612 mg/mL	Injection, SolutionIntravascular	Slate Run Pharmaceuticals, LLC	70436-219
iopamidol	Iopamidol 755 mg/mL	Injection, SolutionIntravascular	Slate Run Pharmaceuticals, LLC	70436-127